High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
Open Access
- 15 February 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (2) , e9221
- https://doi.org/10.1371/journal.pone.0009221
Abstract
Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment for many cancers. Such therapeutic application in humans requires large numbers of functional NK cells that have been selected and expanded using clinical grade protocols. We established an extremely efficient cytokine-based culture system for ex vivo expansion of NK cells from hematopoietic stem and progenitor cells from umbilical cord blood (UCB). Systematic refinement of this two-step system using a novel clinical grade medium resulted in a therapeutically applicable cell culture protocol. CD56+CD3− NK cell products could be routinely generated from freshly selected CD34+ UCB cells with a mean expansion of >15,000 fold and a nearly 100% purity. Moreover, our protocol has the capacity to produce more than 3-log NK cell expansion from frozen CD34+ UCB cells. These ex vivo-generated cell products contain NK cell subsets differentially expressing NKG2A and killer immunoglobulin-like receptors. Furthermore, UCB-derived CD56+ NK cells generated by our protocol uniformly express high levels of activating NKG2D and natural cytotoxicity receptors. Functional analysis showed that these ex vivo-generated NK cells efficiently target myeloid leukemia and melanoma tumor cell lines, and mediate cytolysis of primary leukemia cells at low NK-target ratios. Our culture system exemplifies a major breakthrough in producing pure NK cell products from limited numbers of CD34+ cells for cancer immunotherapy.Keywords
This publication has 38 references indexed in Scilit:
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activityBlood, 2009
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivoJournal of Clinical Investigation, 2009
- Expression of P2X5 in lymphoid malignancies results in LRH‐1‐specific cytotoxic T‐cell‐mediated lysisBritish Journal of Haematology, 2008
- Generation of Natural Killer Cells from Serum-Free, Expanded Human Umbilical Cord Blood CD34+CellsStem Cells and Development, 2007
- A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immatureBlood, 2007
- Evidence for discrete stages of human natural killer cell differentiation in vivoThe Journal of Experimental Medicine, 2006
- Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancerBlood, 2005
- A novel myeloid-like NK cell progenitor in human umbilical cord bloodBlood, 2003
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cellsHuman Immunology, 2001